Tove Øyjord

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas

VA Flørenes, Eivind Hovig, Tove Øyjord et al. · British Journal of Cancer · 1996 · 107 citations · Full text

Medicine, Molecular Biology, Oncology +14

Metabolic reprogramming supports the invasive phenotype in malignant melanoma

Ingrid J. Bettum, Saurabh S. Gorad, Anna Barkovskaya et al. · Cancer Letters · 2015 · 82 citations · Full text

Medicine, Cancer Biology, Oncology +14

Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors

Caroline E. Nunes‐Xavier, Karine Flem‐Karlsen, Christina Tekle et al. · Oncotarget · 2016 · 80 citations · Full text

Medicine, Cancer Biology, Oncology +13

TP53 allele loss, mutations and expression in malignant melanoma

VA Flørenes, Tove Øyjord, R Holm et al. · British Journal of Cancer · 1994 · 73 citations · Full text

Veterinary Medicine, Molecular Genetics, Oncology +14

Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein geneEGP-2

Hiltje de Graaf, Gunhild M. Mælandsmo, Paal Ruud et al. · International Journal of Cancer · 1997 · 48 citations · Full text

Medicine, Cell Biology, Oncology +13